See more : Future Supply Chain Solutions Limited (FSC.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Core Laboratories N.V. (CLB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Core Laboratories N.V., a leading company in the Oil & Gas Equipment & Services industry within the Energy sector.
- Silver Scott Mines, Inc. (SILS) Income Statement Analysis – Financial Results
- Intra Energy Corporation Limited (IEC.AX) Income Statement Analysis – Financial Results
- Seafco Public Company Limited (SEAFCO.BK) Income Statement Analysis – Financial Results
- Medica Group Plc (MGP.L) Income Statement Analysis – Financial Results
- Oriola Oyj (OKDBV.HE) Income Statement Analysis – Financial Results
Core Laboratories N.V. (CLB)
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 509.79M | 489.74M | 470.25M | 487.27M | 668.21M | 700.85M | 659.81M | 594.74M | 797.52M | 1.09B | 1.07B | 981.08M | 907.65M | 794.65M | 695.54M | 780.84M | 670.54M | 575.69M | 483.47M | 427.43M | 405.64M | 364.75M | 376.57M | 336.10M | 303.70M | 286.20M | 214.90M | 105.40M | 80.10M |
Cost of Revenue | 415.74M | 410.82M | 386.41M | 395.63M | 518.18M | 520.05M | 499.18M | 469.52M | 560.11M | 691.97M | 688.44M | 644.74M | 593.37M | 513.79M | 457.77M | 514.78M | 449.19M | 407.10M | 368.12M | 336.39M | 326.92M | 301.31M | 293.31M | 268.66M | 245.40M | 220.50M | 170.50M | 84.70M | 64.20M |
Gross Profit | 94.05M | 78.92M | 83.84M | 91.63M | 150.03M | 180.80M | 160.63M | 125.23M | 237.41M | 393.26M | 385.07M | 336.34M | 314.28M | 280.86M | 237.77M | 266.05M | 221.35M | 168.59M | 115.34M | 91.04M | 78.72M | 63.44M | 83.26M | 67.44M | 58.30M | 65.70M | 44.40M | 20.70M | 15.90M |
Gross Profit Ratio | 18.45% | 16.11% | 17.83% | 18.81% | 22.45% | 25.80% | 24.34% | 21.06% | 29.77% | 36.24% | 35.87% | 34.28% | 34.63% | 35.34% | 34.18% | 34.07% | 33.01% | 29.28% | 23.86% | 21.30% | 19.41% | 17.39% | 22.11% | 20.07% | 19.20% | 22.96% | 20.66% | 19.64% | 19.85% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 40.26M | 38.12M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.93M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | -1.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 38.89M | 38.12M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 41.14M | 33.03M | 30.37M | 31.65M | 33.84M | 33.08M | 37.85M | 28.14M | 22.79M | 20.18M | 15.93M | 13.54M | 12.30M | 8.40M | 6.00M | 3.60M | 2.70M |
Other Expenses | 515.00K | -722.00K | 5.60M | -1.83M | -5.32M | 737.00K | -452.00K | 344.00K | -3.67M | -1.07M | 338.00K | 4.12M | 22.38M | 20.91M | 20.62M | 28.54M | 3.66M | 11.95M | 16.57M | 16.38M | 22.61M | 22.50M | 27.78M | 19.22M | 18.70M | 16.50M | 11.00M | 4.60M | 3.10M |
Operating Expenses | 39.41M | 37.40M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 63.53M | 53.94M | 50.99M | 60.19M | 37.50M | 45.03M | 54.41M | 44.52M | 45.40M | 42.68M | 43.71M | 32.76M | 31.00M | 24.90M | 17.00M | 8.20M | 5.80M |
Cost & Expenses | 455.15M | 448.21M | 430.59M | 429.67M | 566.21M | 582.96M | 546.92M | 508.91M | 609.84M | 737.62M | 740.43M | 687.92M | 656.89M | 567.73M | 508.76M | 574.97M | 486.69M | 452.13M | 422.54M | 380.91M | 372.32M | 343.99M | 337.02M | 301.41M | 276.40M | 245.40M | 187.50M | 92.90M | 70.00M |
Interest Income | 0.00 | 11.57M | 9.15M | 14.37M | 14.69M | 0.00 | 0.00 | 0.00 | 56.00K | 403.00K | 776.00K | 319.00K | 138.00K | 249.00K | 0.00 | 848.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 13.43M | 11.57M | 9.15M | 14.37M | 14.69M | 13.33M | 10.73M | 11.57M | 12.38M | 10.60M | 9.32M | 8.82M | 10.90M | 15.84M | 15.52M | 6.43M | 0.00 | 0.00 | 0.00 | 0.00 | 7.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 15.78M | 17.16M | 18.52M | 20.87M | 22.61M | 23.09M | 24.52M | 26.87M | 27.46M | 26.70M | 25.47M | 22.92M | 23.30M | 23.27M | 24.33M | 21.77M | 19.48M | 17.69M | 17.06M | 17.40M | 23.54M | 20.10M | 22.54M | 19.22M | 18.70M | 16.50M | 11.00M | 4.60M | 3.10M |
EBITDA | 70.42M | 58.69M | 63.78M | -56.50M | 119.29M | 141.71M | 134.49M | 114.32M | 188.53M | 373.23M | 358.89M | 316.54M | 271.47M | 247.72M | 210.60M | 231.66M | 203.32M | 141.25M | 77.99M | 63.66M | 56.16M | 40.52M | 62.09M | 53.75M | 39.16M | 57.01M | 41.70M | 17.10M | 13.20M |
EBITDA Ratio | 13.81% | 11.98% | 13.56% | 15.73% | 17.85% | 20.22% | 20.82% | 14.49% | 23.07% | 31.93% | 31.06% | 30.30% | 30.19% | 31.48% | 30.35% | 29.26% | 28.04% | 23.65% | 17.41% | 14.77% | 13.79% | 11.86% | 18.67% | 15.77% | 19.89% | 20.34% | 17.36% | 16.03% | 16.35% |
Operating Income | 54.64M | 41.52M | 45.26M | 55.77M | 96.68M | 118.62M | 112.44M | 86.18M | 161.07M | 346.53M | 333.42M | 297.28M | 250.75M | 226.93M | 186.78M | 206.71M | 183.85M | 123.56M | 60.93M | 46.51M | 33.32M | 20.76M | 36.58M | 34.69M | 27.30M | 40.80M | 27.40M | 12.50M | 10.10M |
Operating Income Ratio | 10.72% | 8.48% | 9.63% | 11.45% | 14.47% | 16.93% | 17.04% | 14.49% | 20.20% | 31.93% | 31.06% | 30.30% | 27.63% | 28.56% | 26.85% | 26.47% | 27.42% | 21.46% | 12.60% | 10.88% | 8.21% | 5.69% | 9.71% | 10.32% | 8.99% | 14.26% | 12.75% | 11.86% | 12.61% |
Total Other Income/Expenses | -13.43M | -11.57M | -9.15M | -14.37M | -14.69M | -13.33M | -8.26M | -11.57M | -12.38M | -10.60M | -9.32M | -8.82M | -11.91M | -17.78M | -15.52M | 1.55M | -2.55M | -5.81M | -14.29M | -8.28M | -5.07M | -5.38M | -7.92M | -8.31M | -8.56M | -3.92M | -2.60M | -1.30M | -2.80M |
Income Before Tax | 41.21M | 29.95M | 36.11M | -91.18M | 81.99M | 105.29M | 101.71M | 74.61M | 148.69M | 335.93M | 324.10M | 288.46M | 238.84M | 209.15M | 171.26M | 208.61M | 181.30M | 117.75M | 46.64M | 38.24M | 25.62M | 13.16M | 28.66M | 27.36M | 5.10M | 33.70M | 22.00M | 11.40M | 7.30M |
Income Before Tax Ratio | 8.08% | 6.12% | 7.68% | -18.71% | 12.27% | 15.02% | 15.41% | 12.54% | 18.64% | 30.96% | 30.19% | 29.40% | 26.31% | 26.32% | 24.62% | 26.72% | 27.04% | 20.45% | 9.65% | 8.95% | 6.32% | 3.61% | 7.61% | 8.14% | 1.68% | 11.77% | 10.24% | 10.82% | 9.11% |
Income Tax Expense | 4.19M | 10.30M | 15.89M | 5.90M | -12.29M | 25.45M | 18.61M | 10.75M | 33.76M | 77.31M | 80.91M | 71.85M | 54.20M | 63.75M | 57.16M | 65.00M | 60.19M | 35.09M | 14.93M | 10.22M | 6.92M | 5.53M | 8.02M | 8.21M | 1.70M | 10.10M | 6.60M | 3.70M | 2.20M |
Net Income | 36.68M | 19.45M | 19.73M | -97.07M | 101.98M | 79.53M | 83.13M | 63.90M | 114.85M | 257.49M | 242.81M | 216.07M | 184.68M | 144.92M | 113.60M | 143.60M | 121.11M | 82.66M | 31.21M | 12.29M | 18.70M | -9.06M | 20.63M | 19.15M | 3.40M | 20.00M | 15.40M | 7.70M | 4.20M |
Net Income Ratio | 7.19% | 3.97% | 4.19% | -19.92% | 15.26% | 11.35% | 12.60% | 10.74% | 14.40% | 23.73% | 22.62% | 22.02% | 20.35% | 18.24% | 16.33% | 18.39% | 18.06% | 14.36% | 6.46% | 2.88% | 4.61% | -2.48% | 5.48% | 5.70% | 1.12% | 6.99% | 7.17% | 7.31% | 5.24% |
EPS | 0.79 | 0.42 | 0.51 | -2.18 | 2.11 | 1.80 | 1.88 | 1.45 | 2.71 | 5.90 | 5.38 | 4.66 | 3.99 | 3.23 | 2.47 | 2.85 | 2.58 | 1.65 | 0.60 | 0.23 | 0.31 | -0.14 | 0.31 | 0.28 | 0.04 | 0.30 | 0.31 | 0.18 | 0.11 |
EPS Diluted | 0.77 | 0.42 | 0.50 | -2.16 | 2.10 | 1.79 | 1.88 | 1.45 | 2.68 | 5.77 | 5.28 | 4.54 | 3.82 | 3.00 | 2.43 | 2.74 | 2.48 | 1.54 | 0.56 | 0.22 | 0.30 | -0.14 | 0.30 | 0.27 | 0.04 | 0.29 | 0.30 | 0.17 | 0.11 |
Weighted Avg Shares Out | 46.68M | 46.33M | 46.01M | 44.48M | 44.36M | 44.21M | 44.15M | 43.48M | 42.38M | 43.64M | 45.10M | 46.35M | 46.29M | 44.83M | 45.94M | 46.02M | 47.07M | 50.31M | 52.08M | 53.79M | 60.42M | 66.35M | 66.15M | 64.78M | 62.90M | 58.45M | 50.32M | 43.43M | 40.00M |
Weighted Avg Shares Out (Dil) | 47.52M | 46.81M | 46.69M | 44.97M | 44.65M | 44.47M | 44.26M | 44.15M | 42.91M | 44.60M | 45.99M | 47.55M | 48.39M | 48.24M | 46.66M | 47.89M | 48.82M | 53.78M | 56.02M | 57.52M | 62.36M | 66.35M | 68.54M | 67.08M | 64.89M | 60.50M | 52.00M | 44.71M | 40.00M |
Core Laboratories (CLB) Up 0.9% Since Last Earnings Report: Can It Continue?
Why Devon Energy, Phillips 66, and Core Laboratories All Slumped Today
Core Laboratories (CLB) Q4 Earnings Beat, Revenues Miss
Core Laboratories N.V. (CLB) Q4 2022 Earnings Call Transcript
Core Laboratories (CLB) Surpasses Q4 Earnings Estimates
Core Laboratories: A Pricey Oil Services Name At Technical Resistance
Core Labs (CLB) Reveals Plans to Transfer Domicile to U.S.
Why ExxonMobil, Chevron, and Core Labs Stocks Popped Today
SLB vs. CLB: Which Stock Is the Better Value Option?
Core Laboratories: Likely To Take A Pause, Patience!
Source: https://incomestatements.info
Category: Stock Reports